Abstract:Objective To explore the clinical application effects of using leuprorelin acetate microspheres before laparoscopic surgery treatment of ovarian endometriomas.Methods 102 cases who diagnosed as ovarian endometriomas patients from January 2012 to July 2014 of our hospital were selected.Patients were average divided into control group and study group according to random method,and each group was 51 cases.All patients in two groups were given laparoscopic surgery.Patients in study group were given hypodermic injection leuprorelin acetate microspheres before operation,but patients in control group were given any treatment.Pelvic pain relief rate,recurrence rate,symptom relief rate,pregnancy rate and blood loss during operation in two groups were observed.Results The pelvic pain remission rate in study group was obvious higher than that of control group,and the difference was statistical significance(χ2=12.5269,P= 0.0004);the recurrence rate in study group was obvious lower than that of control group,and the difference was statistical significance(χ2=7.4128,P=0.0065);the pregnancy rate and symptoms remission rate in study group was obvious higher than that of control group respectively,and the difference was statistical significance(P<0.05);the average bleeding volume during operation in study group was less than that of control group,and the difference was statistical significance (t=9.7203,P=0.0000).Conclusion Using leuprorelin acetate microspheres before laparoscopic surgery treatment of ovarian endometriomas with better effects,which can obviously enhance the symptoms remission rate and pregnancy rate,decrease bleeding during operation and is worth to popularize in clinical for its great clinical meaning.
黎佩莹;陈健华;殷婉萍;许虎云;李栩萍;李子琳. 卵巢子宫内膜异位囊肿腹腔镜手术前应用醋酸亮丙瑞林微球的效果研究[J]. 中国当代医药, 2016, 23(15): 81-83.
LI Pei-ying;CHEN Jian-hua;YIN Wan-ping;XU Hu-yun;LI Xu-ping;LI Zi-lin. Effects study of using leuProrelin acetate microsPheres before laParoscoP-ic surgery treatment of ovarian endometriomas. 中国当代医药, 2016, 23(15): 81-83.